Q-Line Biotech Limited

* GAMMA-GT PLUS;

* Glucose PAP;

* Glycated Serum Protein Assay;

* HDL Cholesterol (Direct);

* Homocysteine;

* High-sensitivity C-reactive protein (hs-CRP);

* IRON;

* Lactate;

* LDH-P;

* LDL Cholesterol (Direct);

* lipase;

* Lipo Protein (a): Lp(a);

* Magnesium Xylidyl;

* Phosphorus;

* RF Latex;

* RF Turbilatex;

* TIBC;

* Total Protein Plus;

* Trig Mono;

* Urea UV;

* Uric Acid Mono.

@The Company has made a fresh application pursuant to the change in the constitution of the Company.

iii. Approvals obtained by the Company for the premises situated at Industrial Property bearing No. C-108, Nariana Industrial Area, Phase - I, New Delhi - 110028.

1. Letter bearing no. TU/IV-RD/4989/2024 issued by Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India on March 27, 2024 for recognition of in-house R&D at the said premises and the recognition of this in-house R&D is valid till March 31, 2026.

2. The Company has obtained a letter dated June 11, 2025 bearing no. TU/IV-RD/4989/2024 taking on record the change in the legal status of the Company from "Q-line Biotech Private Limited" to "Q-line Biotech Limited" in relation to its in-house R&D unit at the said premises.

3. The Company has obtained the licenses under the Factories Act, 1948 in relation to this premises which are as follows:

a. Factory License bearing no. NFL1202423961 having date of approval as May 13, 2025 and date of generation as May 12, 2025 under the Factories Act, 1948 for the ground floor of the said premises as factory and the rules made thereunder for use of the ground floor of the said premises as a Factory for the medical transcription services with 10 H.P. and is valid till March 31, 2028.

b. Factory License bearing no. NFL1202319953 having date of approval and date of generation as May 13, 2025 under the Factories Act, 1948 and the rules made thereunder for the 1st floor of the said premises as a factory for the medical transcription services with 5 H.P. and is valid till March 31, 2028.

c. Factory License bearing no. NFL1202319956 having date of approval and date of generation as May 13, 2025 under the Factories Act, 1948 and the rules made thereunder for use of the 2nd floor of the said premises as a factory for the medical transcription services with 5 H.P. and is valid till March 31, 2028.

d. Factory License bearing no. NFL1202319954 having date of approval and date of generation as May 13, 2025 under the Factories Act, 1948 and the rules made thereunder for use of the 2nd floor of the said premises as a factory for the medical transcription services with 5 H.P. and is valid till March 31, 2028.

e. Factory License bearing no. NFL1202423962 having date of approval as May 13, 2025 and date of generation as May 12, 2025 under the Factories Act, 1948 and the rules made thereunder for use of the 3rd floor of the said premises as a factory for the medical transcription services with 10 H.P. and is valid till March 31, 2028.

4. The Company has obtained the following licenses under the Drugs and Cosmetics Act, 1940:

279